Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

According to Dr. Patrick Lu, CEO of Sirnaomics, Dr. Lebel's ...

According to Dr. Patrick Lu, CEO of Sirnaomics, Dr. Lebel's promotion will enrich Sirnaomics' ability to advance its clinical-stage and pre-clinical RNAi-based treatments. Dr. Lebel himself expressed commitment to lead Sirnaomics' RNAi pipeline through clinical development to the commercial stage.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
5357 Views
Comment
Sign in to post a comment